• Die Fortschritte der Forschung sind die einzige Hoffnung der Patienten auf wirksame Therapien!

  • Unterstützen Sie die Forschung an seltenen genetischen Muskelkrankheiten!

New transnational call for rare diseases

The European Joint Programme on Rare Diseases (EJP RD) calls for Proposals on “Pre-clinical research to develop effective therapies for rare diseases".

Call conditions
Pre-proposals by February 18th

**********************************************************************

Translational Summer School 2020

Leiden, 6-10 July

The summer school is targeted at MDs, PhD/Postdoc researchers and others working in translational research in the NMD or RD field. 

registration open

*****************************************************

The 25th International Annual Congress of the World Muscle Society

Halifax, 30 September - 4 October 2020

The main thematic topics of this year are: New developments in congenital muscle disease, Gene modifiers and gene delivery in neuromuscular disorders, Advances in the treatment of neuromuscular disorders.

Student Abstract submission until March 2nd
General abstract submission until April 2nd
Early bird registration until March 2nd

*****************************************************************

Funding opportunity

The German-Dutch-Austrian association on central nuclear myopathies launches an international call for research programs on centronuclear myopathies.

Deadline for proposals submission: March 31st

***************************************************************************

STIM1 long and STIM1 gate differently TRPC1 during store-operated calcium entry.

Dyrda A, Koenig S, Frieden M.
Cell Calcium. 2020 Mar;86:102134.

17 Februar 2020

mTORC 1 signalling is not essential for the maintenance of muscle mass and function in adult sedentary mice.

Ham AS, Chojnowska K, Tintignac LA, Lin S, Schmidt A, Ham DJ, Sinnreich M, Rüegg MA.
J Cachexia Sarcopenia Muscle. 2020 Feb;11(1):259-273

13 Februar 2020

Evaluation of the NAD+ biosynthetic pathway in ALS patients and effect of modulating NAD+ levels in hSOD1-linked ALS mouse models.

Harlan BA, Killoy KM, Pehar M, Liu L, Auwerx J, Vargas MR.
Exp Neurol. 2020 Jan 31;327:113219

31 Januar 2020

PHD1 controls muscle mTORC1 in a hydroxylation-independent manner by stabilizing leucyl tRNA synthetase.

D'Hulst G, Soro-Arnaiz I, Masschelein E, Veys K, Fitzgerald G, Smeuninx B, Kim S, Deldicque L, Blaauw B, Carmeliet P, Breen L, Koivunen P, Zhao SM, De Bock K.
Nat Commun. 2020 Jan 10;11(1):174.

15 Januar 2020